Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions

Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-12-02. On CanQuery you can follow the original downloads. Files are available in English and French.

Anyone can find out if a submission has been accepted for review by Health Canada by searching the submissions under review list. We publish Regulatory Decision Summaries (RDS). These summaries explain the purpose of the submission and the reason(s) for Health Canada’s decision on certain health products seeking market authorization. You can access RDSs through the Drug and Health Product Register.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-12-02

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data